Regular articlePreemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade
Under an Elsevier user license
open archive
Cited by (0)
Supported in collaboration of the Mayo Clinic Center for Individualized Medicine, National Institutes of Health grants U19 GM61388 (The Pharmacogenomics Research Network), R01 GM28157, U01 HG005137, R01 CA138461, R01 AG034676 (The Rochester Epidemiology Project), and U01 HG06379 and U01 HG06379 Supplement (The Electronic Medical Record and Genomics or eMERGE Network).
Disclosures: J.L.B., III, holds stock and receives royalties from Oneome LLC and AssureX Health.
© 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.